Pyrimidindionverbindungen gegen Herzerkrankungen

Details

Veröffentlichungs-Nr.

EP4744664

Anmeldetag

19. Juni 2014

Veröffentlichung

20. Mai 2026

Rechtsraum

EP

IPC

A61K31/513(WARNER LAMBERT CO et al.)

Abstract

Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.

Anmelder

Firma

MyoKardia, Inc.

Land

🇺🇸 USA